Plain-English translation of ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new investigational medication called , which will be given intravenously (through an IV) in combination with standard chemotherapy drugs that are already approved for treating advanced colorectal cancer. The study will determine whether the medication is safe and whether it helps slow or shrink the cancer better than standard treatment alone.
Colorectal cancer that has spread to other parts of the body is difficult to treat, and doctors need better options to help patients live longer and healthier lives. This trial is exploring whether the new treatment can improve results beyond what current standard therapies alone can achieve.
You likely qualify if…
You likely don't qualify if…
You would visit a hospital or clinic regularly for IV infusions and blood tests to check how the treatment is working and monitor for side effects. The study has two phases: first, doctors will test increasing doses of the new medication combined with standard chemotherapy to find the right dose; then, you may be randomly assigned to receive one of those optimized doses or standard treatment alone. The entire study lasts approximately 6 years, and you should expect more frequent appointments and medical assessments than you would with standard care alone.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States